Although AZ is a tumor suppressor and its expression can prevent cell growth and tumorigenesis, AZIN1 competes with ODC to release ODC from the ODC-AZ complex based on the stronger binding ability of AZIN1 and AZ, which is conducive to the polyamine synthesis pathway and promotes cancer progression (100, 106). The gene discussed is AZIN1; the disease is neoplasm.